Gather insights from our experts here at HCG on delivering personalized and actionable content to an HCP at every point in their journey. Additionally, read on to understand how to measure and analyze the success of each engagement in order to adapt the content, channels, and timing to improve effectiveness and fulfil HCPs’ unmet needs.
The total amount of data that an HCP needs to consume has significantly increased since the dawn of the smartphone era. On average, the data consumed were 2 zettabytes in 2010, and in 2025, the projected consumption of data will be 181 zettabytes.
Read on to learn about our approach to tackling this using omnichannel.
Join an HCG cross-functional panel as they discuss the Precision Medical Education journey and how it will lead to personalized, actionable content, and when and where it will have the greatest impact. The panel will also discuss how to measure and analyze successes through an engagement and how to adapt the content, channels, and timing to improve effectiveness over time.
COVID-19 significantly changed consumer behaviors and required pharma to rethink how we engage and educate HCPs. Our experts discuss how to prepare for the new future of medical communications, taking learnings from what we've witnessed and experienced over the last several years to propel our engagements forward.
Our experts discuss the need to think personal and snackable when developing content, the evolution to “Content 3.0,” and how to master the new landscape to engage HCPs and key opinion leaders (KOLs) on social media.
Members from the HCG Engagement Group, an industry powerhouse collection of 115+ digital, creative, and innovation experts, discuss a strategy for effective knowledge building among HCP audiences, tactical real-world examples and considerations, and a framework for leveraging data-driven audience segmentation and social network engagement.
The Science Behind Learning: Evidence-Based Principles to Improve HCP Engagement
Medical, scientific, and creative experts translate learning theory research into best practices for improving HCP engagement. An overview of research in learning techniques and methodologies, actionable real-world examples, and a framework for integrating learning principles into future medical communications will be provided.
You’ve heard it, DOLs are the new KOLs—and this model is here to stay. From identifying them through a common passion to building this relationship, we’ve been there, done that, and we’re ready to take you on this journey!
With the rise of online HCP presence, a new breed of KOLs have emerged—DOLs. Our experts will provide their key insights on identification, engagement, and advocacy in this article.
HCG experts provide their perspective on the evolving role of DOLs in medical and marketing communications and share their approaches for identifying, monitoring, and engaging DOLs in a compliant manner, with relevant examples.
Learn strategies on how to engage an HCP audience at virtual congresses—from the virtual booth to relationship building, the increased audience size, to content. Anyone trying to engage HCPs in a virtual environment need to rethink their strategy, and we have a few suggestions on how.
A multidisciplinary expert HCG panel discusses HCP attitudes, opinions, and preferences on the return to live events, as told by HCPs themselves. The panel discusses “what’s next” in HCP engagement and provides insights on integrated multichannel strategies for connecting and communicating with both live and virtual audiences during hybrid programs.
Communication professionals engage a cross-functional panel to discuss challenges, share learnings, and highlight best practices when presenting at a virtual (or hybrid) congress, based on findings from 100 virtual congresses. The panel investigates competitive differentiation and how to maximize audience outreach using real-life examples.
Data-dissemination and digital experts provide perspectives on what congress disruption means for medical communications strategy to equip attendees with practical solutions for data dissemination and HCP engagement.
HCG hosts a panel of industry experts to discuss how to interpret data from clinical trials disrupted by the COVID-19 pandemic and how to best communicate these data with regulators.
An HCG and industry expert panel discusses how to prepare a high-quality product concept document and develop specifications around the components of the product. They also consider how to effectively use these utility documents to guide regulatory, business development, scientific, and market-entry strategy and development.